Menstrual Blood Cells Repair Cartilage
Analysis based on 6 articles · First reported Apr 10, 2026 · Last updated Apr 13, 2026
This medical breakthrough could significantly impact the biotechnology and pharmaceutical industries by offering a novel cell-free therapy for Osteoarthritis, a condition affecting over 600 million people. The development by Kaunas University of Technology researchers may lead to new investment opportunities in regenerative medicine and biomaterials.
Researchers at Kaunas University of Technology, including Dr. Ilona Uzielienė and Dr. Edvinas Krugly, have discovered a promising cell-free therapy for Osteoarthritis. This therapy utilizes extracellular vesicles derived from menstrual blood stromal cells, which have shown potential to stimulate cartilage repair. The study, published in Scientific Reports, demonstrated that these vesicles can improve cartilage cell function and slow tissue degradation, even in older postmenopausal women. The team is also developing biomimetic scaffolds to protect and gradually release these fragile vesicles, enhancing treatment outcomes. This interdisciplinary research aims to provide a non-invasive and effective solution for Osteoarthritis, a condition currently lacking treatments that can halt or reverse cartilage degeneration.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard